The muscarinic acetylcholine receptor (mAChR) of both brain and myocardium is an integral membrane sialoglycoprotein of molecular mass approx. kDa (Birdsall r t al., 1979; Berrie ef al., 1985h; Haga & Haga, 1985; Peterson et al., 1986) . The carbohydrate moiety has been estimated to contribute between 6 and 20 kDa to the overall molecular mass (Rauh C I al., 1986; Peterson et al., 1986) . Variations in the extent or character of glycosylation may account for part of the molecular mass heterogeneity which has been reported for the mAChR in exocrine glands (Hootman ef al., 1985) .
The similarity of the gross molecular properties of mAChR's in several different tissues and species has been emphasized (Venter, 1983 ). Yet. the receptor is pleiotropic, regulating several different tissue responses through coupling to apparently distinct GTP-binding proteins; these directly G-coupled responses include inhibition of adenylate cyclase (Jakobs c't a Hulme et al., 1981) , hydrolysis of polyphosphoinositides (Sasaguri et al., 1985) and the opening of K + channels (Pfaffinger et al., 1985 , Breitweiser & Szabo, 1985 . I t is possible that several different, but similar, mAChR gene products with specialized effector recognition sites are needed to interact selectively with these distinct mechanisms (Michell & Houslay, 1986) , although it appears that the purified porcine brain receptor can activate both Gi and Go (Haga et al.. 1985; Kurose et ul.. 1986) .
A further complicating factor is the occurrence of subtypes of mAChR's, which are differentiated by selective antagonists such as pirenzepine (Pz) (Hammer P I al., 1980; Birdsall & Hulme, 1983) but not by 'classical' antagonists such as N-methylscopolamine (NMS) (Hulme et al., 1978) . For Pz, the rank order of potency for mAChR in different tissues is forebrain/autonomic ganglia > exocrine glands (e.g. lacrimal) > myocardium. After solubilization of the receptors in digitonin, the selectivity of Pz, although still present, is altered, the rank order now being forebrain > myocardium > lacrimal (Berrie et al., 1985a (Berrie et al., , 1986 Birdsall (11 ul., 1986) . These tissues express different balances between the mAChR-response coupling mechanisms, yet no clear linkage can be identified between the different subclasses of Pz-binding sites and individual coupling mechanisms (Brown P I al., 1985; Harden P I al., 1986) . The origin of the subclasses of Pz-binding sites is therefore unknown.
The resolution of these questions evidently requires the purification of the mAChR's from different tissues, elucidation of their primary structures, and pharmacological repertoire, and determination of the number of gene products expressed.
Pur$cation 01' the mAChR ,from rat .forebrain
The mAChR was purified from rat forebrain membranes as described previously (Berrie ef al., 1985b; Wheatley et al., 1986) . The procedure involved solubilization of the receptor in digitonin, then. sequentially, ion-exchange chromatography on DEAE-Sephacel, and two rounds of affinity chromatography on o-aminobenzhydryloxytropane (ABT)-Sepharose (Haga & Haga, 1983) , using carbachol as the eluting ligand. The overall purification was 3000-7000-fold, with a yield of 15% of the binding activity present in the initial supernatant.
The purified preparations had a very reproducible polypeptide composition when visualized on SDS/polyacrylamide gels (Fig. I ). There was a dominant 70 kDa polypeptide which was noticeably broader than the standard bands, compatible with a glycoprotein character. This band co-electrophoresed with purified receptor labelled with the alkylating affinity ligand ['H]propylbenzilylcholine mustard (['HIPrBCM) (Birdsall r t al., 1979) . All of the impurity polypeptides were de-enriched during affinity chromatography, suggesting that they were not complexed with the receptor. In agreement with this, the receptor, labelled with ['HINMS, was recovered from 5-20% sucrose gradients as a sharp, monodisperse peak with s ? " ,~ 1 1.3 S, which behaved as the free ligand-binding protein, and showed no evidence of the presence of the 13.5s mAChR-G-protein complex identified previously (Berrie et al., 1984) . This agrees with the absence from the preparations of the characteristic G-protein banding pattern. Further purification of the mAChR polypetide for peptide mapping and sequencing studies was achieved by SDS/polyacrylamide-gel electrophoresis of the fully reduced, carboxymethylated preparation, followed by excision and electro-elution of the receptor band as described by Hunkapiller ef al.
( 1 983) (Fig. I) . Recovery of the intact mAChR polypeptide was approx. 60%, and its estimated purity was 70-100%. Re-running on SDS/polyacrylamide-gel electrophoresis now showed a single, apparently homogeneous, band ( 
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Binding properties of the affinity-puriJied mACh R The ligand-binding properties of the affinity-purified mAChR were, in a gross sense, very similar to those of the membrane-bound receptor, or the receptors present in the initial digitonin supernatant. However, close examination revealed differences. Thus, the binding of NMS to the purified preparation was slightly weaker (Kd = 4.5 x 1 0 -l '~) than to the membranes or initial supernatant (Kd = 2 x 10 M). The binding of the agonist, oxotremorine-M (OXOM), was complex. A constant feature was the presence of a major population (4Cr80Y0) of low-affinity sites with Kd of approx. 6 x 1 0 -6~, resembling the low-affinity sites seen in membranes (Birdsall et al., 1978) . However, there was also a population of high-affinity sites, whose relative proportion varied from 20 to 60% and whose affinity also varied, with Kd values in the range 10-9-3 x lo-". Although forebrain membranes contain sites with such affinities, the unpurified digitonin supernatant displayed only low-affinity agonist-binding sites. As expected, the binding of oxoM to the purified mAChR was unaffected by GTP analogues.
The binding of Pz was also altered by purification. Pz recognized two subclasses of binding sites in forebrain membranes, with Kd values of approx. IO-'and 3 x IO-'M (Hammer el al., 1980) . After solubilization, Pz continued to be able to discriminate the two populations of sites (Berrie et af., 1985~) . The high-affinity Pz sites were depleted during affinity chromatography, and were essentially absent from the purified preparation, perhaps reflecting selective proteolysis (Berrie et d., 1985a) , or selective retention on ABT-Sepharose. However, the properties of the residual sites were not identical with those of the low-affinity Pz sites; the Kd for Pz was 5 x IO-*-IO-'M, intermediate between the high-and low-affinity 'binding states seen in the initial supernatant.
It was suspected that oxidation of sulphydryl groups might contribute to the change in binding properties. In confirmation of this, the addition of dithiothreitol (DTT, 1 mM) to the purified preparation led to conversion of 73% of the binding sites to a form having a Kd of approx. 1 0 -6~ (Fig. 2) , a value similar to that found in solubilized lacrimal gland preparations (Berrie et al., 1986) , and close to the low-affinity end of the spectrum of Pz binding affinities. The interconversion was almost complete at 1 mM-DTT; there was no effect on NMS binding at these DTT concentrations.
DTT also affected the binding of oxoM, causing partial conversion of high-to low-affinity binding sites (data not shown). The importance of these findings is that the isolated purified mAChR, under conditions in which it was monomeric, and free from the influence of DTT-activated proteases, was capable of manifesting a range of complex binding activity similar to that seen in membranes.
In addition to the effects of DTT, which we have observed, treatment of membrane bound mAChR's with the thiolmodifying agent p-chloromercuribenzoate has been shown to establish the ability of Pz to discriminate between highand low-affinity binding sites in the cerebral cortex (Birdsall et al., 1983a,b) and largely to eliminate the heart/cortex selectivity of the ligand. The oxidation state of key thiol residues, therefore, must make a critical contribution to determining the structure and pharmacology of the receptor binding site.
Proteolytic digestion of the purified mAChR
In order to remove bound SDS from the electro-eluted mAChR the protein was precipitated with 95% ethanol at -20"C, with greater than 90% recovery. The pronounced hydrophobic character of the receptor prevented its resuspension in detergent-free aqueous media, even in the presence of guanidinium hydrochloride.
The receptor, trace-labelled with '"1 and immobilized on a plastic surface, was therefore digested with TPCK-trypsin in situ (trypsin/mAChR ratio 1 : 50, w/w). There was an initial rapid release of peptides into the supernatant followed by a slower, prolonged phase of release. About 30% of the 1251-labelled polypeptide chain was released after exhaustive digestion. By contrast, digestion of the receptor in which the binding site was labelled with ['HIPrBCM liberated very little radioactivity, showing that the peptide labelled by this reagent is not hydrophilic. SDS/polyacrylamide-gel electrophoresis of the soluble fraction showed that the peptides were small, mainly having molecular masses in the range 2-5 kDa (Fig. 3) . The insoluble fraction was extracted into SDS. and shown to contain larger peptides in the range 4-12 kDa, particularly 5-8 kDa, in addition to a small amount of labelled material in the 29-36kDa range (Fig. 3) . Analysis of the ['HIPrBCMcontaining peptide showed a discrete, labelled peptide of I I kDa, again accompanied by a small amount of higher molecular mass material (Fig. 3) .
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Reversed-phase h.p.1.c. analysis of the soluble peptides showed that the rapidly released receptor fragments underwent further processing. Eventually, a predominant radiolabelled end product was obtained, which eluted at 31% acetonitrile (Fig. 4) . A small amount of this peptide (approx. 80 pmol) was purified, and subjected to gas-phase sequencing. The N-terminal sequence Asp-Tyr-Asn-ThrGly-Met-was determined at the 10pmol level. Since the peptide is a tryptic fragment, it must succeed a lysine or arginine residue. Comparison with the P-receptor sequence shows some homology with a peptide in the C-terminus of the hamster-lung P,-adrenergic receptor (Dixon et al., 1986) with the sequence Lys-Thr-Asp-Tyr-Met-Gly-. We therefore believe that the peptide derives from the C-terminal region of the mAChR.
The solvent system ethanol/formic acid/water (70 : 26 : 4, by vol.) (Gerber et al., 1979) solubilized an additional 38% of the tryptic peptides from both the '"1-and [3H]PrBCMlabelled mAChR, although there was still a substantial insoluble residue in both cases; in particular the [3H]PrBCMlabelled peptides were notably insoluble.
Some fractionation was obtained by gel filtration on Sephadex LH60 (Fig. 5) . The 1251-labelled peptides eluted in a broad, fairly symmetrical peak centred on an apparent molecular mass of approx. 4.2 kDa, but extending to greater than 8kDa, in agreement with the results of SDS/polyacrylamide-gel electrophoresis analysis. The [jH]PrBCMlabelled peptides were biased towards the higher molecular mass range, and there was evidence for the labelling of a discrete species with molecular mass in excess of 8 kDa, again supporting the results of SDS/polyacrylamide-gel electrophoresis studies.
In conclusion, our structural studies are consistent with the assumption that, like the B-adrenergic receptor (Dixon et al., 1986) , the structure of the mAChR is closely analogous to that of rhodopsin (Pappin et af., 1984) . As a working hypothesis, we propose that the mAChR has a short, extracellular N-terminal segment, which is glycosylated, followed by a number of transmembrane segments (there are thought to be seven of these, in the case of rhodopsin) joined by extramembranous loops. This part of the structure should contain the binding site, and contribute to the predominant population of hydrophobic 4-12 kDa peptides generated by trypsin. Its flexibility, and hence its ability to bind conformationally restricted molecules such as Pz, is evidently affected by the oxidation state of key cysteine residues.
The transmembrane domain is proposed to be followed by a C-terminal cytoplasmic tail, which would participate in the recognition of GTP-binding proteins, and would be the predominant source of the water-soluble tryptic peptides which we have observed.
Our studies indicate the existence of sequence homology between the C-terminal regions of the mAChR and the /3-adrenergic receptor. The full extent of such homology remains to be determined.
